Table 6: Analysis of associations between antidiabetic drug combinations and HbA1c levels in the study population by multinomial logistic regression analysis.
|
Category |
p-value |
OR |
95% C.I. for OR |
|
|
Lower |
Upper |
|||
|
Biguanides + DPP-4 inhibitor / HbA1c |
0.04* |
2.605 |
1.026 |
6.613 |
|
Biguanides + Sulfonylureas + DPP-4 inhibitor / HbA1c |
0.051 |
2.769 |
0.995 |
7.708 |
|
Biguanides + Sulfonylureas + SGLT2 inhibitor / HbA1c |
0.154 |
2.139 |
0.752 |
6.085 |
|
Biguanides + SGLT2 inhibitor + DPP-4 inhibitor / HbA1c |
0.028* |
3.268 |
1.134 |
9.414 |
|
Biguanides + Sulfonylureas + DPP-4 inhibitor + SGLT2 inhibitor / HbA1c |
0.094 |
2.172 |
0.876 |
5.385 |
Multinomial logistic regression analysis; OR: Odds Ratio; C.I: Confidence interval; * = p < 0.05